1351813-70-1 Usage
General Description
7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is a chemical compound with the molecular formula C7H3BrClN3. It is a heterocyclic compound with a pyrazolo[4,3-b]pyridine backbone, and it contains bromine and chlorine as substituents on the 7th and 5th carbon atoms, respectively. 7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine has potential applications in the pharmaceutical industry, particularly in the development of new drugs and agrochemicals. It may also be used in research as a building block for the synthesis of other heterocyclic compounds. However, due to its specific chemical structure and reactivity, it may also pose certain health and environmental risks, and thus should be handled and used with appropriate caution and care.
Check Digit Verification of cas no
The CAS Registry Mumber 1351813-70-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,1,8,1 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1351813-70:
(9*1)+(8*3)+(7*5)+(6*1)+(5*8)+(4*1)+(3*3)+(2*7)+(1*0)=141
141 % 10 = 1
So 1351813-70-1 is a valid CAS Registry Number.
1351813-70-1Relevant articles and documents
MACROCYCLES AS PDE1 INHIBITORS
-
, (2019/06/30)
The present invention provides macrocycles of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
-
, (2019/07/10)
The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
-
, (2018/09/25)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
